BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GlobeImmune, Inc. 

1450 Infinite Drive

Louisville  Colorado  80027  U.S.A.
Phone: 303-625-2700 Fax: 303-625-2710


SEARCH JOBS








 Company News
Colorado-Based GlobeImmune, Inc. Gives IPO A Second Shot, Aims For $35 Million 3/18/2014 7:36:16 AM    More...
Biotech GlobeImmune, Inc. Withdraws $60 Million IPO 11/1/2013 7:44:57 AM    More...
GlobeImmune, Inc. Offers IPO Details 9/6/2012 8:26:34 AM    More...
GlobeImmune, Inc. Files Paperwork for $69 Million IPO 7/3/2012 6:21:39 AM    More...
GlobeImmune, Inc.'s GI-4000 in Combination With Gemcitabine Following Surgery Shows Evidence of an Improvement in Survival in a Phase 2b Clinical Trial With Ras Mutation Positive Pancreas Cancer 6/27/2012 9:09:15 AM    More...
GlobeImmune, Inc. Initiates Phase 1 Clinical Trial of GI-6301 in Brachyury Expressing Cancers 2/8/2012 11:43:28 AM    More...
Gilead Sciences Ltd. (GILD) and GlobeImmune, Inc. Announce License and Collaboration Agreement to Develop Therapeutic Vaccine Products for Treatment of Chronic Hepatitis B Infection 10/25/2011 9:07:48 AM    More...
GlobeImmune, Inc. Promotes Jeffrey Dekker to Vice President of Finance 8/31/2011 8:47:43 AM    More...
GlobeImmune, Inc. Receives Three Grants Under Federal Therapeutic Discovery Project Program 11/3/2010 8:56:37 AM    More...
Phase 2b Study Demonstrates GlobeImmune, Inc.'s GI-5005 HCV Therapeutic Vaccine Increases Sustained Virologic Response by 12 Percent in Patients Who Previously Failed Therapy With Standard of Care 11/1/2010 9:27:51 AM    More...
123456

//-->